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ABSTRACT  
Aims: To summarize findings from the STORK-Groruddalen Study regarding ethnic differences in the 
prevalence of gestational diabetes (GDM) by the WHO and modified International Association of Diabetes 
and Pregnancy Study Groups (IADPSG) criteria (no one hour value), insulin resistance, β-cell function and 
physical activity (PA) level. 
Methods: Population-based cohort study of 823 healthy pregnant women (59% ethnic minorities). Data 
from questionnaires, fasting blood samples, anthropometrics and objectively recorded PA level (SenseWear 
Armband), were collected at <20 (Visit 1) and 28±2 (Visit 2) weeks of gestation. The 75-g OGTT was 
performed at Visit 2. Insulin resistance (HOMA-IR) and β-cell function (HOMA-β) were estimated from 
venous fasting plasma glucose and C-peptide. 
Results: The GDM prevalence was 13.0% with the WHO and 31.5% with the IADPSG criteria. The ethnic 
minority women, especially South Asians, had highest figures. South and East Asian women had highest 
HOMA-IR at Visit 1 after adjustment for BMI. HOMA-IR increased from Visit 1 to Visit 2 irrespective of 
ethnic origin. Compared with Western European women, the absolute and percentage increase in HOMA-β 
from Visit 1 to Visit 2 was poorest for the South and East Asian women. All ethnic groups walked less and 
spent less time in moderate-to-vigorous physical activity (MVPA) during weekend days compared with 
weekdays. South Asian women were least active, measured by steps and by time spent in MVPA. 
Conclusion: Alarmingly high rates of GDM were found, highest among South Asians. South Asian women 
were less physically active, more insulin resistant and showed poorer β-cell compensation compared with 
Western Europeans. 
 
 
INTRODUCTION 
 
Today, increasing rates of gestational diabetes mellitus 
(GDM), defined as any degree of glucose intolerance 
with onset or first recognition during pregnancy, are 
reported from several continents (1,2). This trend is 
linked to the global epidemic of obesity, and reflects 
the underlying prevalence of type 2 diabetes (T2DM) 
in women of reproductive age in the background popu-
lation. Comparison of prevalence figures for GDM 
between study populations is hampered by the lack of 
consensus about diagnostic criteria and screening 
procedures (3), in addition to the differences in pre-
pregnancy BMI, age and ethnic origin. The Internatio-
nal Association of Diabetes and Pregnancy Study 
Groups (IADPSG) proposed new criteria for GDM in 
2010 (Table 1) (4). These were based on the findings 
from the Hyperglycaemia and Adverse Pregnancy Out-
come (HAPO) study, showing a continuous relationship 
between maternal glucose levels and adverse fetal out-
comes. The IADPSG criteria were set to reflect an odds 
ratio (OR) of at least 1.75 for neonatal birth weight, 
cord C-peptide or per cent body fat above the 90th 
percentile compared with neonates of women with 
glucose values below the mean. However, other ORs 
were discussed (4). The IADPSG criteria were adopted 
by the American Diabetes Association (ADA) in 2011 
(5). However, the Carpenter and Coustan criteria have 
been widely used in North America (6), and the WHO 
(7) and European Association for the Study of Dia-
betes (EASD) (8) criteria in Europe (Table 1). 
 Overweight and obese women start their pregnancy 
more insulin resistant compared with normal weight 
women (9). To maintain normoglycaemica during 
pregnancy, an increase in insulin secretion is needed to 
compensate for the pregnancy-induced insulin resis-
tance (10). Pregnant women without contraindications 
are recommended to spend 30 minutes on most, if not 
all days of the week, in moderate-to-vigorous-intensity 
physical activity (MVPA) (11). Pregnant women are 
reported to be less physically active than non-pregnant 
women both in leisure-time and at work (12). 
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Table 1.  Gestational diabetes mellitus diagnostic thresholds for 75-g and 100-g oral glucose tolerance tests. Values 
are from venous plasma (mmol/l). 
 
  
75-g oral glucose 
tolerance test  
100-g oral glucose 
tolerance test 
 
World Health 
Organization criteria (7) 
European Association 
for the Study of 
Diabetes (8) 
International Association of 
Diabetes and Pregnancy 
Study Groups (4) 
Carpenter and 
Coustan (6)*  
Fasting ≥ 7.0 ≥ 6.0 ≥ 5.1 ≥ 5.3 
1 h   ≥ 10.0 ≥ 10.0 
2 h ≥ 7.8 ≥ 9.0 ≥ 8.5 ≥ 8.6 
3 h    ≥ 7.8 
*Two values above thresholds necessary for a diagnosis of Gestational diabetes mellitus. 
 
 Ethnic minority groups, which are often socially dis-
advantaged (13), have a higher prevalence of T2DM 
(14) and GDM (15). Studies from Europe have found 
that women originating from African and Middle 
Eastern countries, tend to enter their pregnancies with 
higher BMI levels than the ethnic majority population 
in each country (16,17), while women of South and 
East Asian descent overall were leaner that the Euro-
pean population. However, these findings need to be 
interpreted in view of studies showing substantial 
ethnic differences in the amount of body fat relative to 
BMI, especially in Asians (18). The body fat per-
centage appears to be from 1-8% higher among Asians 
compared with Caucasians at a given BMI, sex and 
age (19). 
 The STORK Groruddalen Study was set up in Gro-
ruddalen, a part of Oslo, covering affluent as well as 
more deprived residential areas, with 82 000 inhabitants 
of which about 40% are ethnic minorities, with a 
diverse socioeconomic status (20). The majority (75-
85%) of pregnant women residing in the area attend 
the Child Health Clinics for antenatal care. In this 
paper we summarize the main published findings from 
the STORK Groruddalen Study regarding ethnic diffe-
rences in 1) the prevalence of GDM by the WHO and 
modified IADPSG criteria (17), 2) insulin resistance 
and beta cell function from early pregnancy to 28 
weeks of gestation (21) and 3) objectively recorded 
physical activity (PA) level in early gestation (22). 
Lastly, we will discuss the public health aspects of 
GDM. 
 
 
METHODS 
 
Design, data collection  
The STORK Groruddalen study is a population-based 
cohort study, conducted at three public Child Health 
Clinics in Oslo, Norway, from May 2008 to May 2010 
(20). The Regional Ethics committee and The Norwe-
gian Data Inspectorate approved the study protocol. 
Information material and questionnaires were transla-
ted to Arabic, English, Sorani, Somali, Tamil, Turkish, 
Urdu and Vietnamese. Women were eligible if they 1) 
lived in the districts, 2) planned to give birth at one of 
two study hospitals, 3) were less than 20 weeks preg-
nant, 4) could communicate in Norwegian or any of 
the above specified languages and 5) were able to give 
a written consent. Women with pregestational diabetes 
or other diseases necessitating intensive hospital 
follow-up during pregnancy, were excluded. In short, 
questionnaire data, objectively recorded PA, venous 
fasting blood samples and anthropometrics (body 
height measured to the nearest 0.1 cm, and body weight 
to the nearest 0.1 kg by Tanita-BC 418MA) were 
collected at Visit 1 in early pregnancy (V1, mean; 
standard deviation (S.D.), gestational week 15.0 (3.4) 
(17,20). The same data (not background information) 
were collected at Visit 2 (V2) in weeks 28±2 of gesta-
tion, when the 75 g oral glucose tolerance test (OGTT) 
also was performed.  
Main variables  
Ethnicity 
Ethnicity may be defined as the social group a person 
belongs to, which implies both shared culture, history, 
geographical origins, language, lifestyle factors, physi-
cal, genetic and other factors (23). Ethnic origin was 
defined by the participant’s country of birth or the par-
ticipant’s mother’s country of birth if the participant’s 
mother was born outside Europe or North-America 
(20). Women with ethnic origin from Eastern Europe, 
Asia, Africa, and South- and Central America are refer-
red to as ethnic minority women, and constituted 59% 
of the sample, with the largest groups being South 
Asian (25%) and Middle Eastern (15%). Western Eu-
ropeans, with the majority born in Norway (93.6%) or 
Sweden or Denmark (3.2%), constitute the reference 
group.  
GDM definitions, insulin resistance and β-cell function 
At V2, fasting plasma glucose (FPG) and 2-hour plas-
ma glucose (PG) from the OGTT was measured on site 
in venous EDTA blood (HemoCue 201+, Angelholm, 
Sweden) (17). GDM was diagnosed with the WHO 
criteria: FPG ≥7.0 or 2-hour PG ≥7.8 mmol/l (7), and 
modified IADPSG criteria: FPG ≥5.1 or 2-hour PG 
≥8.5 mmol/l (4), as 1-hour PG values were not avail-
able (Table 1). 
 The homeostatic model assessment (HOMA) was 
used to estimate insulin resistance (HOMA-IR) and β-
cell function (HOMA-β) at V1 and V2 (21). The 
Oxford University HOMA Calculator 2.2 was used 
with FPG and fasting C-peptide concentrations (24). 
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Table 2.  Baseline characteristics of the total cohort, stratified into Western European and ethnic minority women, and further into ethnic 
origin. Data are mean (SD), unless otherwise stated. 
 
 Total 
Western 
Europe1 
Ethnic 
minority 
Eastern 
Europe2 South Asia3 East Asia4 
Middle 
East5 Somalia 
Sub-S. Afr. / 
South Am.6 
N  % 759 100.0 313 41.2 446 58.8 42 5.5 188 24.8 39 5.1 112 14.8 35 4.6 30 4.0 
Years of maternal age 29.9 (4.8) 30.9 (4.5) 29.1 (4.9) 28.7 (4.1) 28.7 (4.5) 31.0 (4.6) 29.4 (5.4) 28.5 (5.8) 29.4 (5.8) 
Parity, n %                   
Nulliparous 347 45.7 162 51.7 185 41.5 27 64.3 78 41.5 16 41.0 38 33.9 13 37.1 13 43.3 
Uniparous 261 34.4 116 37.1 145 32.5 12 28.6 62 33.0 16 41.0 39 34.8   5 14.3 11 36.7 
Multiparous (≥ 2) 151 19.9   35 11.2 116 26.0   3   7.1 48 25.5   7 18.0 35 31.3 17 48.6   6 20.0 
Educational level*, n %                   
< 10 years schooling 123 16.3   10   3.2 113 25.3   5 12.2 33 17.6   8 20.5 42 37.5 21 60.0   4 13.3 
Secondary s., 10-12 y. 297 39.5   95 30.6 202 45.7 14 34.1 94 50.3 16 41.0 50 45.5 11 31.4 17 56.7 
University/college 333 44.2 206 66.2 127 28.7 22 53.7 60 32.1 15 38.5 18 16.4   3   8.6   9 30.0 
Employed*, n % 525 70.0 272 87.5 253 57.6 31 75.6 115 62.2 31 79.5 52 46.8   9 26.5 15 51.7 
1° relatives with diabetes*, n % 194 25.6   40 13.0 154 35.6   8 19.5 88 47.3   6 15.8 42 38.5   6 20.0   4 13.4 
Gestational week at inclusion   15 (3.4)   14 (2.3)   16 (3.9) 15 (3.1) 16 (3.9) 16 (3.9) 15 (3.3) 18 (5.5) 16 (3.8) 
Body height (cm) 163.7 (6.7) 167.4 (5.6) 161.1 (6.1) 166.2 (5.8) 160.0 (5.6) 157.2 (6.1) 161.2 (5.5) 164.1 (5.8) 161.6 (6.3) 
BMI prepregnant* (kg/m2) 24.6 (4.8) 24.6 (4.8) 24.6 (4.9) 23.8 (4.4) 23.7 (4.1) 22.3 (3.4) 25.9 (5.1) 26.8 (6.5) 26.3 (5.8) 
*Incomplete data on the variables because of missing values for 6-19 women. 
1Norway: 93.6%, Sweden and Denmark: 3.2%, other Western Europe (includes North America n=3): 3.2% 
2Poland: 16.7%, Russia: 14.3%, Kosovo: 14.3%, other Eastern Europe: 54.8% 
3Pakistan: 62.2%, Sri Lanka: 30.9%, other South Asia: 6.9% 
4Vietnam: 43.6%, Philippines: 28.2%, Thailand: 10.3%, other Eastern Asia: 17.9% 
5Iraq: 30.4%, Turkey: 22.3%, Marocco:19.6%, Afghanistan:10.7%, other Middle East: 16.8% 
6Sub-Sahara Africa: 53.3%, South/Central America: 33.3%, Nigeria: 13.3% 
 
 
For these analyses, FPG was measured from venous 
blood on gel tubes, analysed at the Department of 
Multidisciplinary Laboratory Medicine and Medical 
Biochemistry, Akershus University Hospital (Vitros 
5.1 FS, Ortho Clinical Diagnostics, slide adapted 
colorimetric method). Fasting C-peptide was measured 
at the Hormone Laboratory, Oslo University Hospital 
by non-competitive immunofluorometric assays 
(DELFIA, PerkinElmer Life Sciences, Wallac Oy, 
Turku, Finland)  
Objective recordings of physical activity 
PA was objectively recorded at V1 with SenseWear™ 
Pro3 Armband (BodyMedia Inc., Pittsburgh, PA, USA) 
(22), according to protocol and worn the following 4-7 
days, only removed for bathing/water activity. Hours 
of MVPA and steps, per weekday and weekend day, 
are reported. At least 19.2 hours (80%) of one day of 
Armband use was required to be registered with valid 
data (22). The cut-off points defining MVPA were 3 
metabolic equivalents (METs). The device has been 
found valid in free living activities (25), and in preg-
nant women (26,27). 
 
The study sample in the three papers  
In total, 823 (74% of eligible) women were included 
(20), 772 met at V2, and 759 women with valid OGTT 
data could be classified according to the GDM criteria 
(17). These 759 women constitute the study sample for 
the analyses related to the GDM prevalence. Baseline 
characteristics are presented in Table 2. No significant 
differences were found in baseline characteristics be-
tween those with and without OGTT data. 
 There were 695 singleton pregnant women with 
available FPG and C-peptide values from both V1 and 
V2 (21). These women constitute the study sample for 
the analyses related to HOMA figures. No significant 
differences between those with and without valid data 
were found with respect to age, parity, prepregnant 
BMI, body height, level of education or Western Euro-
pean vs. ethnic minority origin. 
 The 678 women with valid Armband data constitute 
the study sample for the analysis related to objectively 
recorded PA at V1 (22). Mean age, weeks of gestation 
at inclusion, body mass, height and BMI did not differ 
between women with valid PA recordings and those 
without. 
 
Statistical analyses  
Simple descriptive tests were used as appropriate. 
Bonferroni-corrections for multiple testing were done. 
Multiple logistic regression analyses were performed 
to identify the effect of ethnic origin on GDM with the 
WHO and modified IADPSG criteria separately. Age, 
prepregnant BMI and parity were entered as adjust-
ment covariates in model A, thereafter education and 
body height (used as a proxy for early life socio-
economic status) in model B, and lastly first degree 
relatives with diabetes in model C. Interactions were 
tested. ORs with 95% CI were estimated. Multiple 
linear regression analyses were performed with 
HOMA-IR at V1 and percentage change in HOMA-β 
from V1 to V2 as dependent variables. Adjustments 
were done for gestational week and ethnic origin, and 
further for prepregnant BMI. The residuals were 
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checked for normality and independence. SPSS (Sta-
tistical Software package) versions 18 and 19 were 
used in the analyses for these two papers. 
 Regarding the paper on PA, multivariate linear re-
gression models using robust regression were applied, 
with hours of MVPA or steps per weekday or weekend 
day as dependent variables, with BMI, ethnic origin, 
education, occupation, age, gestational week and 
parity as independent variables (core set variables). All 
multivariate models included adjustments for hours 
and days with PA recordings. The final main-effects 
model was tested for interactions between ethnicity 
and parity, education and occupation. We also checked 
for interactions between parity and BMI. Statistical 
analyses related to PA were performed with Number 
Cruncher Statistical System 2007 Version 07.1.12 
(NCSS, LLC, Kaysville, Utah, USA). For all analyses 
the statistical significance level was set to 5%. 
 
 
RESULTS 
 
Baseline characteristics  
The mean (S.D.) maternal age was 29.9 years (4.9) and 
the prepregnant BMI was 24.5 kg/m2 (4.8) (Table 2). 
Western European women were older, taller, had 
lower parity and higher education compared to the 
ethnic minority women. Mean prepregnant BMI did 
not differ between Western European and ethnic mino-
rity women. Heterogeneity between the ethnic minori-
ty groups was observed for several variables such as 
prepregnant BMI, parity and education. 
 
GDM by the WHO and IADPSG criteria  
The GDM prevalence with the WHO criteria were 
13.0% overall, 10.9% in Western European and 14.6% 
in ethnic minority women, and increased to 31.5%, 
24.0% and 36.8% respectively, with the modified 
IADPSG criteria (Figure 1). The increase was stron-
gest in South Asian women (2.8 times, compared with 
2.2 times in Western European and Middle Eastern 
women). FPG ≥ 5.1 mmol/l was found in 37.2% of 
South Asian, 35.7% of Middle Eastern and 21.4% of 
Western European women. 
 For GDM with the WHO criteria, ethnic minority 
origin was an independent predictor (South Asians: 
OR (95% CI); 2.24 (1.26-3.97), Middle Eastern 
women: 2.13 (1.12-4.08) adjusted for age, prepregnant 
BMI and parity (Model A) (Table 3). However, when 
education and body height (a proxy for early life 
socioeconomic status) were added (Model B), the in-
creased OR for ethnic minority women was elimina-
ted. Similar results were found in the final model 
(Model C) with additional adjustments for a family 
history of diabetes. A different pattern was found 
when assessing predictors for GDM with the modified 
IADPSG criteria. All models revealed a significantly 
increased OR for GDM for ethnic minority women, 
and adjustment for education, body height and family 
history of diabetes had little impact (Model B and C). 
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Figure 1.  Gestational diabetes prevalence with the WHO 
(white) and modified IADPSG criteria (grey), for the total 
cohort and the main ethnic minority groups, based on 
universal screening with oral glucose tolerance test at Vi-
sit 2 (Gestational week 28 ±2). Crude values, percentage 
(95% CI). 
 
 
Insulin resistance and beta cell function  
The overall insulin resistance measured by HOMA-IR 
increased from median (IQR) 1.1 (0.6) at V1 to 1.7 
(0.9) at V2 (P<0.001). South Asians had higher 
HOMA-IR compared with Western Europeans at both 
visits (Figure 2a). No significant ethnic differences 
were found in the absolute or percentage change in 
HOMA-IR from V1 to V2. The overall β-cell function 
measured by HOMA-β increased from V1 to V2 
(p<0.001). South Asians had higher HOMA-β com-
pared with Western Europeans at V1, but not at V2 
(Figure 2b). Compared with Western European women, 
the absolute and percentage increase in HOMA-β from 
V1 to V2 were less for the South Asian (p<0.005) and 
East Asian (p<0.002) women. 
 In linear regression analyses with HOMA-IR at V1 
as the dependent variable, South Asian and Middle 
Eastern women were more insulin resistant compared 
with Western Europeans after adjustments for gestatio-
nal week at inclusion. After further adjustments for 
prepregnant BMI, South Asians were still more insulin 
resistant, East Asians became more insulin resistant, 
while the Middle Easterners were no longer signifi-
cantly different from the Western Europeans. In analy-
ses with the percentage change in HOMA-β from V1 
to V2 as the dependent variable, the increase in β-cell 
function in East Asian and South Asian was signifi-
cantly less than in the Western European women after 
adjustments for gestational week at inclusion, and 
further for prepregnant BMI. 
 
Objectively recorded physical activity in early 
gestation  
Western European women walked more steps com-
pared with South Asian women per weekday and 
during weekends (p<0.001 for both) (Figure 3a). South 
Asian women walked less than women from the Middle 
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Table 3.  Multiple logistic regression models for the gestational diabetes groups identified with the WHO and the modified 
IADPSG criteria, showing the impact of ethnic origin on gestational diabetes after adjusting for covariates. 
 
 Multiple model A Multiple model B Multiple model C 
WHO n=99 OR 95% CI P OR 95% CI P OR 95% CI P 
Years of maternal age 1.13 1.08 1.19 <0.00
1 
1.13 1.08 1.19 <0.00
1 
1.12 1.06 1.18 <0.00
1 Body height     0.93 0.89 0.97 <0.00
1 
0.92 0.88 0.96 <0.00
1 BMI prepregnant  1.05 1.00 1.09 0.044 1.04 1.00 1.09 0.054 1.04 0.99 1.09 0. 11 
Parous ≥1 2.08 1.29 3.36 0.003 2.29 1.39 3.76 0.001 2.33 1.39 3.90 0.001 
< 10 years education     1.91 1.05 3.47 0.034 1.88 1.01 3.49 0.047 
1° relatives with diabetes         1.89 1.32 2.71 0.001 
Ethnic origin ref. Western Europe    0.026    0.772    0.771 
South Asia 2.24 1.26 3.97 0.006 1.18 0.62 2.27 0.614 0.76 0.38 1.55 0.456 
Middle East 2.13 1.12 4.08 0.022 1.03 0.49 2.16 0.944 0.77 0.35 1.66 0.503 
Other minorities* 1.45 0.77 2.73 0.244 0.82 0.41 1.65 0.580 0.69 0.33 1.43 0.314 
IADPSG n=239 OR 95% CI P OR 95% CI P OR 95% CI P 
Years of maternal age 1.03 1.00 1.07 0.068 1.04 1.00 1.08 0.054 1.03 0.99 1.07 0.116 
Body height     1.01 0.98 1.03 0.641 1.00 0.98 1.03 0.746 
BMI prepregnant  1.10 1.06 1.13 <0.00
1 
1.09 1.06 1.13 <0.00
1 
1.09 1.05 1.13 <0.00
1 Parous ≥1 1.17 0.82 1.65 0.390 1.21 0.85 1.73 0.281 1.15 0.81 1.64 0.438 
< 10 years education     1.50 0.96 2.36 0.078 1.55 0.98 2.45 0.062 
1° relatives with diabetes         1.10 0.83 1.47 0.510 
Ethnic origin ref. Western Europe    <0.00
1 
   <0.00
1 
   0.002 
South Asia 2.94 1.94 4.47 <0.00
1 
2.93 1.84 4.67 <0.00
1 
2.54 1.56 4.13 <0.00
1 Middle East 1.79 1.10 2.93 0.019 1.58 0.92 2.73 0. 00 1.44 0.83 2.51 0. 96 
Other minorities* 1.44 0.91 2.28 0.120 1.35 0.82 2.21 0.234 1.25 0.76 2.06 0.381 
*includes Eastern Europe, East Asia, Somalia and Sub Saharan Africa/South America.  
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Figure 2a)  Insulin resistance assessed by HOMA-IR, and b) β-cell function assessed by HOMA-β for the ethnic 
groups at Visit 1 (white) and Visit 2 (Gestational week 28 ±2) (grey). Crude values, median (95% CI). 
 
 
East (p=0.004) and from other minorities (p=0.03) 
during weekdays, while no significant differences 
were observed between Western European, Middle 
Eastern or women from other minorities. All ethnic 
groups walked significantly less (p<0.001) during 
weekend days compared with weekdays (Figure 3b). 
 In the multivariate linear regression model, the num-
ber of steps at weekdays and weekend days for South 
Asians was lower compared with Western European 
women, after adjustment for education, employment, 
age, gestational week, parity, BMI and time wearing 
the activity monitor. A significant interaction term 
(p=0.008) between ethnicity (Western European vs. 
South Asian) and parity was identified. Having one or 
more children was positively associated with steps 
during weekends in South Asians, while Western Eu-
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Figure 3a)  Steps per week- and weekend day for ethnic groups (mean and 95% CI), and b) hours per week- and 
weekend day of moderate physical activity for ethnic groups (geometric mean and 95% CI). Crude values from Visit 1. 
 
 
ropean women walked more steps when nulliparous. 
Furthermore, South Asian women spent less time in 
MVPA at weekdays and weekend days compared with 
Western European women after adjustment for core set 
variables. A significant interaction term for ethnicity 
and educational level was also found when both steps 
and MVPA at weekend days were the dependent vari-
ables. High education was positively associated with 
steps and MVPA during weekends in Western Euro-
pean but not in South Asian women. 
 
 
DISCUSSION 
 
To our knowledge, the STORK Groruddalen popula-
tion-based study is the first to compare the prevalence 
of GDM by the WHO and the IADPSG criteria, assess 
insulin resistance and β-cell function and objectively 
record PA levels in pregnant women with diverse 
ethnic origin. Based on universal OGTT screening, the 
prevalence of GDM with the WHO criteria was 11% 
in Western European and 15% in ethnic minority wo-
men, but increased to 24% and 37% respectively with 
the modified IADPSG criteria. In early gestation, East 
and South Asian women were more insulin resistant 
compared with Western Europeans. Women from all 
ethnic groups, irrespective of baseline levels, became 
equally more insulin resistant from early gestation to 
28 weeks of gestation, but the β-cell function of East 
and South Asians did not compensate to the same ex-
tent as in the Western Europeans. Furthermore, South 
Asian women walked less and spent less time in 
MVPA than Western European women, and parity and 
educational level influenced both measures of PA du-
ring weekend days differently in these ethnic groups. 
 The prevalence of GDM by the WHO criteria was 
higher than suspected in Western European women, 
and higher than in most (28), but not all (29,30) studies 
of similar populations. GDM prevalence figures repor-
ted from Europe range from 1 to 22% (3). Observed 
differences may be attributed to ethnic origin of the 
populations studied, secular trends for obesity and 
maternal age, and not least the preference for selective 
screening with lower sensitivity in most studies (3,31). 
The prevalence of GDM with the modified IADPSG 
criteria in our study was higher than in the HAPO 
study (18%, range 9.3–25.5%). (32). Similar high rates 
as we found in the ethnic minorities, have been repor-
ted in other high risk ethnic groups (38%) (33), which 
may be underrepresented in the HAPO cohort. 
 In line with other studies (34,35), the Middle Eastern 
women in our study had a higher mean BMI, which 
explained their higher insulin resistance. Our finding 
that East and South Asian women became more insulin 
resistant after adjustments for BMI is in accordance 
with other studies (36,37), and supported by findings 
that Asians have more fat per BMI unit compared with 
Western subjects (19). Regardless of ethnic origin and 
baseline level, the insulin resistance increased approxi-
mately 40-45% from early pregnancy to 28 weeks of 
gestation, in line with previous reports (9). However, 
the β-cell response observed for women from East and 
South Asia was less than in their Western European 
counterparts. The β-cell response in relation to the 
pregnancy induced insulin resistance was more ade-
quate for the East Asians compared with South Asians. 
Furthermore, the East Asians had higher 2-hour PG 
values than the South Asians (17). This is in line with 
the HAPO study, reporting that East Asian women 
were less likely to have a GDM diagnosis based on the 
FPG value compared with women at other HAPO 
study sites (32). 
 We did not identify other studies from Europe 
exploring ethnic differences in PA level in pregnancy 
based on objective recordings, but one study from the 
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US assessed MVPA levels and found that ethnic mino-
rity women (African American, Hispanics or Pacific 
Islanders) were less likely than white American women 
to engage in PA (38). Also from studies based on self-
reported PA, pregnant White American women are 
more likely to engage in PA compared with ethnic mi-
nority women in the US (39,40). Others have reported 
no statistically significant association between ethnici-
ty and PA (41,42), which concur with our findings 
related to the other ethnic groups (Middle Eastern and 
Other background). Our findings of substantially lower 
levels of steps and MVPA in weekdays and weekend 
days in South Asian women compared with other eth-
nic minority and Western women, are also in line with 
several studies, mostly based on self-reports, from 
non-pregnant women (43). This may partly be related 
to cultural factors, transmitted over generations. 
 Strengths of our study are the population-based 
design and the multi-ethnic cohort including recently 
immigrated and illiterate women often excluded from 
research, the high attendance rate and minimal loss to 
follow-up at V2, objectively recorded PA and universal 
OGTT screening (17,21,22). The study sample was 
found fairly representative for the largest ethnic groups 
(17,20). The results should be relevant outside the Nor-
wegian context as similar ethnic minority groups live 
in many countries. Limitations are dealt with in detail 
in the respective papers (17,21,22). Obviously, small 
numbers in some ethnic minority groups limits the 
power in some analyses. As we did not measure 1-h 
PG, the IADPSG prevalence might be underestimated. 
The HOMA is a surrogate measure of insulin resis-
tance and β-cell function (44), but is feasible in large 
studies and has been validated in pregnant women (24, 
45). Although objectively recorded PA is less prone to 
underestimation due to recall and social desirability 
bias, wearing the Armband may be a motivational fac-
tor resulting in overestimation of habitual activity. 
 
Implications for public health  
Pregnancy complications like GDM seem to be early 
markers of disturbances in glucose metabolism (10), 
endothelial dysfunction and hypertension (46), which 
in turn, predicts future risk of T2DM in the mother. 
Women with previous GDM may have a 7-fold risk of 
future T2DM, compared with normal pregnancies (47). 
However, T2DM may be prevented or postponed in 
these women by moderate lifestyle changes (48). 
 Until now, a 2-step screening procedure has mostly 
been used in clinical practice and research, implying 
that only women with specified risk factors have had 
an oral glucose tolerance test, which is the gold stan-
dard for a definite diagnosis of GDM. The IADPSG 
has proposed universal screening in gestational week 
24-28 (4). The lower diagnostic FPG threshold as sug-
gested by the IADPSG, will have a major effect on the 
numbers diagnosed (32,49). Concerns related to the 
implications of the IADPSG criteria are being add-
ressed, such as potentially negative consequences of 
labelling a large number of women (some at relatively 
low risks) based on a test with poor reproducibility 
(49,50), the increased work load (51) and the question-
able cost-effectiveness of interventions in late preg-
nancy (50). Although positive short-time effects are 
observed (52,53), only a marginal effect on the preva-
lence of macrosomia can be expected (50). 
 Prepregnant obesity, increasing maternal age and 
family history of diabetes are established risk factors 
for GDM (28). Ethnic minority women tend to get 
GDM at a younger age and a lower BMI than Western 
European women (54). The role of PA in relation to 
GDM is not clear, although higher levels of PA prior 
to and in early gestation are associated with a protec-
tive effect (55). The lack of knowledge is probably 
partly due to the poor performance of self-reported 
PA, when assessing the dose-response relationship 
between PA levels and GDM. Our data are based on 
objective recordings of PA, and we will explore the 
relationship between PA and GDM in more detail. 
Socioeconomic status and early life factors, often mea-
sured with body height, are inversely associated with 
GDM in several studies (28). 
 There is now strong evidence supporting that early 
development plays a central role in determining an 
individual’s risk of later adult disease (56), by mecha-
nisms of developmental plasticity, including epigenetic 
processes enabling the development of a phenotype 
appropriate for the environment in which the offspring 
is predicted to live (57). If there is a mismatch between 
this environment and the actual environment the off-
spring is born into, increased susceptibility to obesity, 
T2DM and cardiovascular disease might develop (58). 
In line with this perspective, we found that ethnic 
differences in OR for GDM by the WHO criteria 
disappeared after adjusting for relevant covariates and 
socioeconomic factors. The results were slightly diffe-
rent for GDM by the IADPSG criteria, which so far 
seem to be driven more by adiposity itself. Both mater-
nal GDM and obesity are independently associated 
with increased birth weight in the offspring (59). This 
may create a “vicious cycle” where the increasing 
prevalence of obesity and T2DM in the mothers 
endorses obesity (60) and related risks factors for non-
communicable diseases in later generations (56). 
These findings, and the developmental origin of health 
and disease concept, support that new public health 
initiatives need to focus more on early life interven-
tions, as interventions in adulthood have shown limited 
results (57). Follow-up data of offspring from inter-
vention trials for women with GDM are so far not 
convincing (61). This may indicate that the window of 
opportunity to prevent long term predisposition to 
obesity may be earlier in fetal life than the currently 
recommended time of screening for GDM. Only 
population-based approaches to improve living condi-
tions and promote a healthy lifestyle, may effectively 
modify the trends for the global obesity and T2DM 
epidemic (62), not least in the most susceptible ethnic 
groups (33). 
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Conclusion  
Alarmingly high rates of GDM were found, not least in 
ethnic minority women. The prevalence increased 2.4 
timers when applying the IADPSG criteria. South Asian 
women were most insulin resistant and least physically 
active in early pregnancy, and had the poorest β-cell 
compensation from early pregnancy to gestational 
week 28 and had the highest rates of GDM. Findings 
from the present study may indicate that South Asian 
women without children and with higher education are 
particularly prone to an inactive lifestyle during preg-
nancy. 
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